Disciplined Growth Investors’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
Other funds holding RDHL
GS
AA
FDCDDQ
CAM
Disciplined Growth Investors's RDHL Position: Q3 2022 in Review
Disciplined Growth Investors sold out of Redhill Biopharma (RDHL) in Q3 2022, closing a stake of 811 shares — an estimated $705K sold.
Disciplined Growth Investors first reported a position in RDHL in Q3 2018 and held it in 16 quarters. The position peaked at $21.6M in Q3 2020. 40 funds tracked by Wall St. Rank hold RDHL as of Q3 2022.
- Disciplined Growth Investors reported no remaining Redhill Biopharma position as of Q3 2022 after selling out during the quarter.
- Disciplined Growth Investors sold 811 Redhill Biopharma shares in Q3 2022, an estimated $705K.
- Disciplined Growth Investors first reported a position in Redhill Biopharma in Q3 2018 and held it in 16 quarters.
- Disciplined Growth Investors's Redhill Biopharma position peaked at $21.6M in Q3 2020.
- 40 funds tracked by Wall St. Rank held Redhill Biopharma as of Q3 2022.
Based on Disciplined Growth Investors's 13F filing for Q3 2022, filed 15 Nov 2022.